February 11, 2008 – Aerocrine AB (OMX Nordic Exchange: AERO) announces that the company has entered into a distribution agreement with Chest M.I. Inc. Chest will market and sell NIOX MINO® in Japan.Chest manufactures and sells a large range of products to measure lung function as well oxygen delivery systems for home use.
The company which was founded in 1965 is one of the largest companies in its field with over 50% share of the Japanese market.Chest has an impeccable reputation and impressive market coverage with over 10 local sales offices. Chest will apply for market authorization of NIOX MINO in Japan and then proceed to product launch... [PDF] Aerocrine's Press Release-
Blog Archive
-
▼
2008
(297)
-
▼
February
(25)
- AstraZeneca RECENTIN BR24 Non-Small Cell Lung Canc...
- Aerocrine, Chest M.I. market and sell NIOX MINO in...
- N30 Pharma, Successful Initiation of Human Studies...
- Glenmark, USD 15 million as milestone payments fro...
- BioMarck Pharmaceuticals, FDA Agreement on its P...
- ADVENTRX, Complete ANX-530 Pharmacokinetic Data at...
- Hana Biosciences, Top-Line Phase 1 Clinical Trial ...
- Bayer and Onyx , Update on Phase 3 Trial of Nexava...
- Oncothyreon's PX-478, effective in preclinical mod...
- Strativa Pharmaceuticals, Discontinuation of the D...
- VioQuest Pharmaceuticals, Clinical Trial Agreement...
- GSK's Volibris (ambrisentan), EMEA positive opinio...
- UCB and sanofi-aventis, FDA Approves XYZAL® (levoc...
- Pfizer and The Pfizer Foundation, to Support Cance...
- GlaxoSmithKline, EMEA positive opinion for the app...
- Schering-Plough, ASMANEX (R) TWISTHALER(R) (Mometa...
- MedImmune submitted Biologics License Application...
- Pfizer Japan, Manufacturing and Marketing Authoriz...
- CAS Medical Systems, Placement of 50th FORE-SIGHT ...
- Masimo, New National Standard for CO Screening by ...
- Sanofi Pasteur and Statens Serum Institut , develo...
- TOPIGEN's TPI ASM8 , European Phase 2 Clinical Stu...
- GlaxoSmithKline and TB Alliance, Tuberculosis Drug...
- Sepracor and Nycomed : exclusive development, mark...
- EPIX Pharmaceuticals, Collaboration with Cystic Fi...
-
▼
February
(25)